Literature DB >> 33627730

Equivalent SARS-CoV-2 viral loads by PCR between nasopharyngeal swab and saliva in symptomatic patients.

Isao Yokota1, Takeshi Hattori2, Peter Y Shane3, Satoshi Konno4, Atsushi Nagasaka5, Kimihiro Takeyabu6, Shinichi Fujisawa7, Mutsumi Nishida7, Takanori Teshima8,9,10.   

Abstract

Emerging evidences have shown the utility of saliva for the detection of SARS-CoV-2 by PCR as alternative to nasopharyngeal swab (NPS). However, conflicting results have been reported regarding viral loads between NPS and saliva. We conducted a study to compare the viral loads between NPS and saliva in 42 COVID-19 patients. Viral loads were estimated by the cycle threshold (Ct) values. SARS-CoV-2 was detected in 34 (81%) using NPS with median Ct value of 27.4, and 38 (90%) using saliva with median Ct value of 28.9 (P = 0.79). Kendall's W was 0.82, showing a high degree of agreement, indicating equivalent viral loads in NPS and saliva. After symptom onset, the Ct values of both NPS and saliva continued to increase over time, with no substantial difference. Self-collected saliva has a detection sensitivity comparable to that of NPS and is a useful diagnostic tool with mitigating uncomfortable process and the risk of aerosol transmission to healthcare workers.

Entities:  

Year:  2021        PMID: 33627730     DOI: 10.1038/s41598-021-84059-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  8 in total

1.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens.

Authors:  Wenling Wang; Yanli Xu; Ruqin Gao; Roujian Lu; Kai Han; Guizhen Wu; Wenjie Tan
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

2.  An immunohistochemical study of odontogenic mixed tumours.

Authors:  K Yamamoto; K Yoneda; T Yamamoto; E Ueta; T Osaki
Journal:  Eur J Cancer B Oral Oncol       Date:  1995-03

3.  Reply to Iwata and Yoshimura, and Endo.

Authors:  Isao Yokota; Kentaro Sakamaki; Peter Y Shane; Takanori Teshima
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

4.  Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva.

Authors:  Sumio Iwasaki; Shinichi Fujisawa; Sho Nakakubo; Keisuke Kamada; Yu Yamashita; Tatsuya Fukumoto; Kaori Sato; Satoshi Oguri; Keisuke Taki; Hajime Senjo; Junichi Sugita; Kasumi Hayasaka; Satoshi Konno; Mutsumi Nishida; Takanori Teshima
Journal:  J Infect       Date:  2020-06-04       Impact factor: 6.072

5.  Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19.

Authors:  Mayu Nagura-Ikeda; Kazuo Imai; Sakiko Tabata; Kazuyasu Miyoshi; Nami Murahara; Tsukasa Mizuno; Midori Horiuchi; Kento Kato; Yoshitaka Imoto; Maki Iwata; Satoshi Mimura; Toshimitsu Ito; Kaku Tamura; Yasuyuki Kato
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

6.  Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing.

Authors:  Yuan-Po Tu; Rachel Jennings; Brian Hart; Gerard A Cangelosi; Rachel C Wood; Kevin Wehber; Prateek Verma; Deneen Vojta; Ethan M Berke
Journal:  N Engl J Med       Date:  2020-06-03       Impact factor: 91.245

7.  Saliva is a reliable tool to detect SARS-CoV-2.

Authors:  Lorenzo Azzi; Giulio Carcano; Francesco Gianfagna; Paolo Grossi; Daniela Dalla Gasperina; Angelo Genoni; Mauro Fasano; Fausto Sessa; Lucia Tettamanti; Francesco Carinci; Vittorio Maurino; Agostino Rossi; Angelo Tagliabue; Andreina Baj
Journal:  J Infect       Date:  2020-04-14       Impact factor: 6.072

8.  Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2.

Authors:  Anne L Wyllie; John Fournier; Arnau Casanovas-Massana; Melissa Campbell; Maria Tokuyama; Pavithra Vijayakumar; Joshua L Warren; Bertie Geng; M Catherine Muenker; Adam J Moore; Chantal B F Vogels; Mary E Petrone; Isabel M Ott; Peiwen Lu; Arvind Venkataraman; Alice Lu-Culligan; Jonathan Klein; Rebecca Earnest; Michael Simonov; Rupak Datta; Ryan Handoko; Nida Naushad; Lorenzo R Sewanan; Jordan Valdez; Elizabeth B White; Sarah Lapidus; Chaney C Kalinich; Xiaodong Jiang; Daniel J Kim; Eriko Kudo; Melissa Linehan; Tianyang Mao; Miyu Moriyama; Ji E Oh; Annsea Park; Julio Silva; Eric Song; Takehiro Takahashi; Manabu Taura; Orr-El Weizman; Patrick Wong; Yexin Yang; Santos Bermejo; Camila D Odio; Saad B Omer; Charles S Dela Cruz; Shelli Farhadian; Richard A Martinello; Akiko Iwasaki; Nathan D Grubaugh; Albert I Ko
Journal:  N Engl J Med       Date:  2020-08-28       Impact factor: 176.079

  8 in total
  17 in total

1.  Viral RNA Load and Infectivity of SARS-CoV-2 in Paired Respiratory and Oral Specimens from Symptomatic, Asymptomatic, or Postsymptomatic Individuals.

Authors:  Rebecca L Tallmadge; Melissa Laverack; Brittany Cronk; Roopa Venugopalan; Mathias Martins; XiuLin Zhang; François Elvinger; Elizabeth Plocharczyk; Diego G Diel
Journal:  Microbiol Spectr       Date:  2022-05-16

2.  A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study.

Authors:  Isao Yokota; Peter Y Shane; Kazufumi Okada; Yoko Unoki; Yichi Yang; Sumio Iwasaki; Shinichi Fujisawa; Mutsumi Nishida; Takanori Teshima
Journal:  Lancet Microbe       Date:  2021-05-19

3.  Estimating the impact of control measures to prevent outbreaks of COVID-19 associated with air travel into a COVID-19-free country.

Authors:  Nick Wilson; Michael G Baker; Tony Blakely; Martin Eichner
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

Review 4.  Saliva as a diagnostic specimen for SARS-CoV-2 detection: A scoping review.

Authors:  Yifei Wang; Akshaya Upadhyay; Sangeeth Pillai; Parisa Khayambashi; Simon D Tran
Journal:  Oral Dis       Date:  2022-04-21       Impact factor: 4.068

Review 5.  Comparing saliva and nasopharyngeal swab specimens in the detection of COVID-19: A systematic review and meta-analysis.

Authors:  Kaveh Nasiri; Aleksandra Dimitrova
Journal:  J Dent Sci       Date:  2021-01-29       Impact factor: 2.080

6.  Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities.

Authors:  Qing Yang; Tassa K Saldi; Erika Lasda; Carolyn J Decker; Camille L Paige; Denise Muhlrad; Patrick K Gonzales; Morgan R Fink; Kimngan L Tat; Cole R Hager; Jack C Davis; Christopher D Ozeroff; Nicholas R Meyerson; Stephen K Clark; Will T Fattor; Alison R Gilchrist; Arturo Barbachano-Guerrero; Emma R Worden-Sapper; Sharon S Wu; Gloria R Brisson; Matthew B McQueen; Robin D Dowell; Leslie Leinwand; Roy Parker; Sara L Sawyer
Journal:  medRxiv       Date:  2021-03-05

7.  Salivary Microbial Dysbiosis Is Associated With Peri-Implantitis: A Case-Control Study in a Brazilian Population.

Authors:  Debora Pallos; Vanessa Sousa; Magda Feres; Belen Retamal-Valdes; Tsute Chen; Mike Curtis; Richardson Mondego Boaventura; Marcia Hiromi Tanaka; Gustavo Vargas da Silva Salomão; Louise Zanella; Tania Regina Tozetto-Mendoza; Gabriela Schwab; Lucas Augusto Moyses Franco; Ester Cerdeira Sabino; Paulo Henrique Braz-Silva; Jamil Awad Shibli
Journal:  Front Cell Infect Microbiol       Date:  2022-01-05       Impact factor: 5.293

8.  Population wide testing pooling strategy for SARS-CoV-2 detection using saliva.

Authors:  Eduardo Esteves; Ana Karina Mendes; Marlene Barros; Cátia Figueiredo; Joana Andrade; Joana Capelo; António Novais; Carla Rebelo; Rita Soares; Ana Nunes; André Ferreira; Joana Lemos; Ana Sofia Duarte; Raquel M Silva; Liliana Inácio Bernardino; Maria José Correia; Ana Cristina Esteves; Nuno Rosa
Journal:  PLoS One       Date:  2022-01-28       Impact factor: 3.240

9.  SARS-CoV-2 variants of concern Alpha and Delta show increased viral load in saliva.

Authors:  Kylie L King; Stevin Wilson; Justin M Napolitano; Keegan J Sell; Lior Rennert; Christopher L Parkinson; Delphine Dean
Journal:  medRxiv       Date:  2022-03-24

10.  Performance of Self-Collected Saliva Testing Compared with Nasopharyngeal Swab Testing for the Detection of SARS-CoV-2.

Authors:  Florence Carrouel; Martine Valette; Hervé Perrier; Maude Bouscambert-Duchamp; Claude Dussart; Paul Tramini; Denis Bourgeois
Journal:  Viruses       Date:  2021-05-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.